Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 9.

Journal Article

Bohn, K. P., Foerster, S., Bischof, G., Hammes, J., van Eimeren, T. and Drzezga, A. (2018). Detection of triple-pathology disease windows by means of multimodal imaging in patients with Alzheimer's disease and mild cognitive impairment with probable Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S269 - 2. NEW YORK: SPRINGER. ISSN 1619-7089

Hammes, J., Bischof, G., Anderl-Straub, S., Barthel, H., Beer, A. J., Danek, A., Eickhoff, S., Fassbender, K., Fliessbach, K., Landwehrmeyer, B., Lauer, M., Ludolph, A. C., Prudlo, J., Schroeter, M. L., Sabri, O., Schmidt-Diehl, J., Schneider, A., Semler, E., Wiltfang, J., Drzezga, A., Otto, M. and van Eimeren, T. (2018). Characterization of disease-specific covariance patterns of neurodegeneration in FTLD-variants. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S229 - 1. NEW YORK: SPRINGER. ISSN 1619-7089

Hammes, J., Bischof, G., Fliessbach, K., Giehl, K., Jessen, F., Neumaier, B., Kukolja, J., Onur, I., Drzezga, A. and van Eimeren, T. (2016). Different binding behavior of the Tau-PET tracer [F-18]-AV-1451 in AD and Tau-positive FTLD. J. Neurochem., 138. S. 377 - 378. HOBOKEN: WILEY-BLACKWELL. ISSN 1471-4159

Hammes, J., Hohberg, M., Taeger, P., Wild, M., Zlatopolskiy, B., Krapf, P., Neumaier, B., Schomaecker, K., Kobe, C., Schmidt, M., Dietlein, M. and Drzezga, A. (2018). Uptake In Non-affected Bone Tissue Does Not Differ Between [18f]-DCFPyL And [68Ga]-HBED-CC PSMA PET/CT. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S535 - 1. NEW YORK: SPRINGER. ISSN 1619-7089

Hammes, J., Leuwer, I., Bischof, G. N., Drzezga, A. and van Eimeren, T. (2017). Flortaucipir perfusion PET is a suitable replacement for FDG PET in patients with neurodegenerative diseases. Eur. J. Nucl. Med. Mol. Imaging, 44. S. S250 - 1. NEW YORK: SPRINGER. ISSN 1619-7089

Hohberg, M., Kobe, C., Taeger, P., Hammes, J., Schmidt, M., Dietlein, F., Wild, M., Heidenreich, A., Drzezga, A. and Dietlein, M. (2019). Combined Early and Late [Ga-68]PSMA-HBED-CC PET Scans Improve Lesion Detectability in Biochemical Recurrence of Prostate Cancer with Low PSA Levels. Mol. Imaging. Biol., 21 (3). S. 558 - 567. NEW YORK: SPRINGER. ISSN 1860-2002

Messerschmidt, K., Barthel, H., Brendel, M., Van Eimeren, T., Marek, K., Villemagne, V., Rumpf, J., Saur, D., Schroeter, M., Rullmann, M., Hoffmann, K., Scherlach, C., Rauchmann, B., Schildan, A., Patt, M., Beyer, L., Song, M., Palleis, C., Gehmeyr, M., Fietzek, U., Respondek, G., Sauerbeck, J., Nitschmann, A., Zach, C., Hammes, J., Barbe, M., Onur, O., Jessen, F., Neumaier, B., Barret, O., Madonia, J., Russell, D., Stephens, A., Roeber, S., Herms, J., Boetzel, K., Bartenstein, P., Levin, J., Drzezga, A., Seibyl, J., Hoeglinger, G., Classen, J. and Sabri, O. (2020). [18F]PI-2620 Tau PET to Improve Imaging-Based Diagnosis of PSP. Eur. J. Nucl. Med. Mol. Imaging, 47 (SUPPL 1). S. S94 - 2. NEW YORK: SPRINGER. ISSN 1619-7089

Reifegerst, M., Hohberg, M., Hammes, J., Drzezga, A. and Wild, M. (2018). LuISA - Lu-177-PSMA intelligent szintigraphy application. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S225 - 2. NEW YORK: SPRINGER. ISSN 1619-7089

Taeger, P. A., Hammes, J., Hohberg, M., Wild, M., Schomaecker, K., Kobe, C., Pfister, D., Heidenreich, A., Dietlein, M., Schmidt, M. and Drzezga, A. (2018). Discrete evaluation of multi-cycle Lu-177-PSMA-617-therapy effects on bone versus lymph node metastases in patients with metastasized castrationresistant prostate cancer (mCRPC). Eur. J. Nucl. Med. Mol. Imaging, 45. S. S126 - 1. NEW YORK: SPRINGER. ISSN 1619-7089

This list was generated on Fri Mar 29 05:45:08 2024 CET.